TickerFacts.

A business in context

GYRE research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-01 · 0001140361-26-035189 · Items 7.01,9.01

  2. 8-K · Current report

    Report date 2026-08-26 · 0001140361-26-034401 · Items 7.01,9.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-340448

  4. 8-K · Current report

    Report date 2026-08-07 · 0001193125-26-339223 · Items 2.02,9.01

  5. 4 · Ownership change

    Report date 2026-08-03 · 0001140361-26-031326

  6. 4 · Ownership change

    Report date 2026-08-03 · 0001140361-26-031324

  7. 8-K · Current report

    Report date 2026-07-10 · 0001140361-26-028716 · Items 5.02,7.01,9.01

  8. 8-K/A · Current report

    Report date 2026-05-04 · 0001140361-26-028564 · Items 2.02,9.01

  9. 4 · Ownership change

    Report date 2026-06-10 · 0001140361-26-027008

  10. 4 · Ownership change

    Report date 2026-06-10 · 0001140361-26-027007

  11. 4 · Ownership change

    Report date 2026-06-10 · 0001140361-26-027006

  12. 4 · Ownership change

    Report date 2026-06-10 · 0001140361-26-027005

  13. 4 · Ownership change

    Report date 2026-06-10 · 0001140361-26-027004

  14. 4 · Ownership change

    Report date 2026-06-10 · 0001140361-26-027003

  15. 8-K · Current report

    Report date 2026-06-10 · 0001140361-26-025324 · Items 5.07

  16. 8-K · Current report

    Report date 2026-06-01 · 0001140361-26-023625 · Items 7.01,9.01

  17. 8-K · Current report

    Report date 2026-05-14 · 0001140361-26-021360 · Items 7.01,9.01

  18. 8-K · Current report

    Report date 2026-05-12 · 0001140361-26-020845 · Items 7.01,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-214676

  20. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-209789 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-05-04 · 0001140361-26-018716 · Items 2.01,3.02,3.03,5.02,5.03,7.01,9.01

  22. DEF 14A · Proxy statement

    Report date 2026-06-10 · 0001140361-26-017124

  23. 8-K/A · Current report

    Report date 2026-03-02 · 0001140361-26-015307 · Items 1.01,9.01

  24. 8-K · Current report

    Report date 2026-03-22 · 0001140361-26-010654 · Items 8.01

  25. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-106251

  26. 8-K · Current report

    Report date 2026-03-12 · 0001193125-26-102700 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2026-03-10 · 0001140361-26-009115 · Items 7.01

  28. 8-K · Current report

    Report date 2026-03-02 · 0001140361-26-007249 · Items 1.01,3.02,5.02,5.03,7.01,9.01

  29. 8-K · Current report

    Report date 2026-01-05 · 0001140361-26-000253 · Items 7.01,9.01

  30. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-272383

  31. 8-K · Current report

    Report date 2025-11-07 · 0001193125-25-270524 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-09-10 · 0001140361-25-034506 · Items 8.01,9.01

  33. 8-K · Current report

    Report date 2025-08-18 · 0001140361-25-032295 · Items 5.02,7.01,9.01

  34. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-106644

  35. 8-K · Current report

    Report date 2025-08-05 · 0000950170-25-106525 · Items 2.02,5.02,7.01,9.01

  36. 8-K · Current report

    Report date 2025-06-04 · 0001140361-25-021612 · Items 5.07

  37. 8-K · Current report

    Report date 2025-05-22 · 0001140361-25-020353 · Items 1.01,9.01

  38. 8-K · Current report

    Report date 2025-05-22 · 0001140361-25-020157 · Items 7.01,8.01,9.01

  39. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-068089

  40. 8-K · Current report

    Report date 2025-05-09 · 0000950170-25-067452 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 18 transaction rows18SGrant / award: 15 transaction rows15AExercise / conversion: 32 transaction rows32MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

68 matching transaction rows. Showing 1–50.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-18
2026-06-22
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock3000.00.75
2026-06-18
2026-06-22
Ye WeiguoS · Sale
Disposed
Common Stock3000.06.35
2026-06-18
2026-06-22
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
3000.00.0
2026-06-11
2026-06-15
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock2800.00.75
2026-06-11
2026-06-15
Ye WeiguoS · Sale
Disposed
Common Stock2800.06.17
2026-06-11
2026-06-15
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
2800.00.0
2026-06-10
2026-06-30
Carmichael GordonA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
40000.00.0
2026-06-10
2026-06-30
Epstein David M.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
40000.00.0
2026-06-10
2026-06-30
Weng DanA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
40000.00.0
2026-06-10
2026-06-30
Parry RenateA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
40000.00.0
2026-06-10
2026-06-30
Zhang PingA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
40000.00.0
2026-06-10
2026-06-30
Nussbaum Rodney LA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
40000.00.0
2026-06-10
2026-06-22
Ye WeiguoS · Sale
Disposed
Common Stock5000.06.24
2026-06-10
2026-06-22
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock5000.00.75
2026-06-10
2026-06-22
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
5000.00.0
2026-06-10
2026-06-11
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock6418.00.75
2026-06-10
2026-06-11
Ye WeiguoS · Sale
Disposed
Common Stock6418.06.21
2026-06-10
2026-06-11
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
6418.00.0
2026-06-09
2026-06-22
Ye WeiguoS · Sale
Disposed
Common Stock3000.06.15
2026-06-09
2026-06-22
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock3000.00.75
2026-06-09
2026-06-22
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
3000.00.0
2026-06-09
2026-06-11
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock14500.00.75
2026-06-09
2026-06-11
Ye WeiguoS · Sale
Disposed
Common Stock14500.06.14
2026-06-09
2026-06-11
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
14500.00.0
2026-06-08
2026-06-10
Bergmann Joshua BenjaminA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
50000.00.0
2026-06-08
2026-06-10
Luo YingA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
120000.00.0
2026-06-05
2026-06-08
Ye WeiguoS · Sale
Disposed
Common Stock15401.06.4
2026-06-05
2026-06-08
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock15401.00.75
2026-06-05
2026-06-08
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
15401.00.0
2026-06-04
2026-06-08
Ye WeiguoS · Sale
Disposed
Common Stock19575.06.13
2026-06-04
2026-06-08
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock19575.00.75
2026-06-04
2026-06-08
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
19575.00.0
2026-05-26
2026-05-27
Ye WeiguoS · Sale
Disposed
Common Stock4000.06.1
2026-05-26
2026-05-27
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock4000.00.75
2026-05-26
2026-05-27
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
4000.00.0
2026-05-22
2026-05-27
Ye WeiguoS · Sale
Disposed
Common Stock3500.06.08
2026-05-22
2026-05-27
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock3500.00.75
2026-05-22
2026-05-27
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
3500.00.0
2026-05-21
2026-05-22
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock12820.00.75
2026-05-21
2026-05-22
Ye WeiguoS · Sale
Disposed
Common Stock12820.06.15
2026-05-21
2026-05-22
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
12820.00.0
2026-05-20
2026-05-22
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock9400.00.75
2026-05-20
2026-05-22
Ye WeiguoS · Sale
Disposed
Common Stock9400.06.15
2026-05-20
2026-05-22
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
9400.00.0
2026-05-19
2026-05-20
Ye WeiguoS · Sale
Disposed
Common Stock9120.06.37
2026-05-19
2026-05-20
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock9120.00.75
2026-05-19
2026-05-20
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
9120.00.0
2026-05-18
2026-05-20
Ye WeiguoM · Exercise / conversion
Acquired
Common Stock200.00.75
2026-05-18
2026-05-20
Ye WeiguoS · Sale
Disposed
Common Stock200.06.62
2026-05-18
2026-05-20
Ye WeiguoM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
200.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001124105GYRE THERAPEUTICS, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • CATALYST BIOSCIENCES, INC. · former SEC name · 2015-06-23 to 2023-10-27
  • TARGACEPT INC · former SEC name · 2002-12-16 to 2015-08-19

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$105.76M$112.57M
2023-12-31$113.45M$124.32M
2022-12-31$102.29M$116.69M
2021-12-31$7.34M$9.04M
2020-12-31$20.95M$27.03M
2018-12-31$6.0K$8.0K
2017-12-31$1.02M$1.39M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗